Fingerprint
Dive into the research topics of 'First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
for the IPCAVD006/RV380/HIV-V-A002 Study Group
Research output: Contribution to journal › Article › peer-review
36
Scopus
citations